Clinical Trials on 본 태성 혈소판 증가증
Total 0 results
Nothing found
Sponsors and Collaborators
- S-Biotek Holding ApS
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Sudimplant SAS - Groupe TBR
- University of Applied Sciences Jena
- Rivierduinen, Centre for Personality disorders Jelgersma
- United States Department of Defense (DOD)
- Foshan Sanshui District People's Hospital
- Paulo Sérgio Gomes Nogueira Borges
- Julian Taylor Green
- Arsha Vidya Tirtha
- Lilly PharmaceuticalCompany
- Oblikue Consulting
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Korea Otsuka International Asia Arab
- Gunkang Pharmaceuticals, Inc
- Eurotrials Brasil Consultores Cientificos Ltda
- Plethora Solutions Ltd
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Iyad Naeem Muhammad, PhD
- View Full List
Medical Conditions
- Blepharospasm of Both Eyelids
- Immunologically-induced Lung Disease
- Vibration; Exposure
- Anemia Acute
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Deformity Flexion
- Gray Platelet Syndrome
- Advance Directive Completion
- Testicular Teratoma
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Visual Attention Span Deficit
- Serum Albumin Low
- Huntington Chorea
- Puberty, Delayed
- Malaria,Falciparum
- Thyroid and Parathyroid Surgery
- Chemotherapy-Induced Neutropenia
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Hypothermia Following Anesthesia, Sequela
- Brain Tumor, Primary
- View Full List
Drug Interventions
- Oxycodone
- Rovalpituzumab tesirine
- F520
- MMV390048 120mg
- Cyanoacrylate
- Ebselen
- Vosaroxin
- Standard medical therapy
- S-Adenosyl-Methionine
- Furmonertinib 160 mg
- Cytisine
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Pemetrexed
- ABY-035 i.v.
- Bimatoprost 0.03% eye drops
- Pegfilgrastim
- Sorafenib
- Celecoxib
- Acalabrutinib in combination with VR
- Mineralocorticoid receptor antagonist
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Armenia
- Contract Research Organizations in Austria
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Croatia
- Contract Research Organizations in France
- Contract Research Organizations in Germany
- Contract Research Organizations in Ghana
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Peru
- Contract Research Organizations in South Korea
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Venezuela
- CRO list by country